3.5 h after i.v. injection. As catalytically active iron is potentially toxic and may promote bacterial growth, it Background. I.v. iron is commonly administered to haemodialysis patients suffering from anaemia to may be recommendable to use dosage regimens for i.v.
Introduction
Methods. We followed serum iron, transferrin and transferrin-saturation before and 5-210 min after End-stage renal disease typically results in anaemia, administration of iron saccharate in 12 patients on which is primarily due to deficient renal production of chronic haemodialysis due to end-stage renal disease.
erythropoietin [1, 2] . Most patients undergoing haemoWe measured catalytically active iron by the bleomycindialysis are therefore treated with recombinant human detectable iron (BDI ) assay and transferrin iron forms erythropoietin (rHuEpo). Efficient erythropoiesis durby urea gel electrophoresis, and studied iron-dependent ing rHuEpo medication requires ample amounts of growth of Staphylococcus epidermidis inoculated into iron, and it has been shown that iron delivery to the the serum samples in vitro.
erythroid marrow becomes a restricting factor in the Results. The iron saccharate injection resulted in full stimulation of erythropoiesis [3, 4] . Iron supplementransferrin saturation and appearance of BDI in the tation is therefore routinely used in conjunction with serum in seven out of the 12 patients. BDI appeared rHuEpo therapy. In patients on haemodialysis oral more often in patients with a low serum transferrin iron therapy has proved incapable of maintaining iron concentration, but it was not possible to identify balance in the long term. I.v. iron administration patients at risk based on serum transferrin or ferritin effectively replenishes iron stores and improves iron level before i.v. iron. The average transferrin saturation delivery and has, therefore, become a recommended and BDI level increased until the end of the follow-up therapy for patients on maintenance haemodialysis time of 3.5 h. The appearance of BDI resulted in loss [5] [6] [7] [8] . of the ability of patient serum to resist the growth of In normal conditions, practically all iron in plasma S. epidermidis, which was restored by adding iron-free is bound to transferrin, which keeps the iron in a apotransferrin to the serum. Iron saccharate, added to catalytically inactive form and prevents iron-catalysed serum in vitro, released only little iron and promoted hydroxyl-radical generation [9] . Transferrin-bound only slow bacterial growth, but caused falsely high iron is also inaccessible to most bacteria [10] . I.v. iron transferrin saturation by one routinely used serum administration raises the concerns that it may result in iron assay.
the oversaturation of transferrin and possibly predisConclusions. The results indicate that 100 mg of iron pose patients to the harmful effects of catalytically saccharate often leads to transferrin oversaturation active non-transferrin-bound iron. Such harmful effects and the presence of catalytically active iron within are hydroxyl radical-mediated tissue injury [9, 11] and bacterial infections [10, 12] . Iron preparations currently showed that i.v. ferric-gluconate administration Subjects and methods resulted in transferrin oversaturation, unless it was given as a slow infusion using a low dose [14] . [18] . In line at 5, 30, 90, and 210 min after the whole iron-saccharate another study from the same group, the use of >17 dose had been given. The last sample was collected 48-72 h vials of i.v. iron-dextran over a 5-6 month period was after iron administration at the beginning of the next haemodialysis session. associated with a 20% increase in mortality from infections [19] . Further, Petruta et al. showed that
Iron and transferrin assays patients with functional iron deficiency who were given i.v. iron, manifested impairment of neutrophil function Serum iron was measured by two spectrophotometric [20] . On the other hand, in a recent prospective study methods using ferrozine [22] or ferene-S [23] as the chromogof risk factors for bacteraemia in 988 chronic haemo-enic agents. Serum transferrin was measured by an immunodialysis patients, Hoen et al. found no association turbidimetric method. The transferrin saturation value (%) between the risk of infection and the use of i.v. iron was calculated from the serum iron and transferrin values [21] . Currently, it is unclear whether certain patterns using the formula: serum iron (mmol/l )/transferrin (g/l )×3.8.
Catalytically active iron in serum was determined using of i.v. iron dosing are more harmful than others. the BDI assay [16 ] modified for small serum volumes.
In the present study we have investigated the effect The reagent solutions except the bleomycin were treated of 100 mg of iron-saccharate given as the first dose of with Chelex (Bio-Rad, USA), 300 mg/10 ml solution or i.v. iron supplementation to patients on chronic haemo-800 mg/20 ml for ascorbic acid solution, over night to remove dialysis, on serum-transferrin saturation and possible any excess iron in the chemicals. The assay components were appearance of catalytically active iron. To measure added in the following order: 250 ml 1 mg/ml DNA (Type I more accurately the actual transferrin saturation, we DNA from calf thymus, Sigma), 25 ml 1.5 IU/ml bleomycin sulfate (Sigma), 50 ml 50 mmol/l MgCl 2 , 25 ml of sample, used urea gel electrophoresis, which separates the standard or blank, and finally, 50 ml 8 mmol/l ascorbic acid different transferrin iron forms. Appearance of cata-(Merck, Germany). A measured amount of 25 mmol/l HCl lytically active iron after i.v. iron injection was investi-(about 7 ml ) was added before the sample to adjust the pH gated by the BDI assay and by studying iron-dependent of reagent mixture to 7.4. The mixture was incubated at growth of inoculated Staphylococcus epidermidis in the 37°C for 1 h for the reaction of the possible ferrous-bleomyserum samples. It was found that BDI was detectable cin complexes formed by iron in the sample, which cause and bacteria grew in the serum samples of seven out DNA degradation. The reaction was stopped by the addition of 50 ml 0.1 mol/l EDTA. Aliquots of 250 ml 1% thiobarbituric of the 12 patients after iron-saccharate administration.
Catalytically active iron after i.v. iron-saccharate 1829 acid (Sigma) and 250 ml 25% HCl were added and the mixture obtained from a rich soy broth medium. The growth index was 0 if no growth could be detected within 24 h, and the was incubated at 80°C for 20 min for chromogen formation of the DNA break down products. The samples were cooled maximum value was 1.0 corresponding to growth in the soy broth medium. to room temperature, 1.5 ml of butanol was added and the chromogen extracted into the organic phase by mixing. The samples were centrifuged for 20 min at 2500 g to separate Other reagents the phases. An aliquot (350 ml ) of the clear top phase was pipetted into micotiter plates. The absorbance at 350 nm was Ferric nitrilotriacetic acid (Sigma Chemical Co., St Louis, measured using a microplate reader (Titertek Multiscan RC, MI, USA) was prepared according to Welch and Skinner Labsystems, Finland). The samples were measured in parallel [26 ] and a 1-mmol/l solution was used for the in vitro with a corresponding blank without the addition of bleomy-experiments. Apotransferrin with a purity over 98% and less cin. The absorbance value of the blank was reduced from than 1% iron saturation was produced by the Finnish Red each sample absorbance value. The reagent blank value was Cross Blood Transfusion Service. reduced from the absorbance values of the standards, and a standard curve between 0.1 and 3 mmol/l was calculated by Statistics linear regression from each series.
The iron forms of transferrin were analysed using urea Correlation coefficient for BDI and bacterial growth index polyacrylamide gel (6% acrylamide gels with 6 M urea) values was calculated with simple linear regression electrophoresis according to Williams et al. [24] . Serum The calculated transferrin saturation values were compared with the distribution of transferrin iron forms in urea gel electrophoresis. The serum samples Bacterial growth assay taken before i.v. iron administration contained ironfree apotransferrin and monoferric transferrin, which The growth of bacteria in serum samples in vitro was tested are the main transferrin forms present in normal serum using a multiple drug resistant S. epidermidis strain 16779 ( Fig. 1) . The proportions of the monoferric and diferisolated from a neutropenic patient with a septic infection at ric transferrins increased after i.v. iron administration.
the Department of Bacteriology of HUCH Diagnostics, Samples with calculated transferrin saturation of Helsinki University Hospital. The strain was precultivated >80% contained mainly diferric transferrin in urea in soy broth (bioMeriuex, France) overnight to produce the inoculum. The bacteria were harvested by centrifugation, gel electrophoresis and no iron-free transferrin. washed and suspended in saline. An iron-poor chemical Transferrin saturation values calculated from the ferrodefined medium at pH 7.4 [25] was used to dilute the serum zine-based iron determinations matched well with the samples to a final dilution of 1/5. The medium was not able distribution of the different transferrin iron forms in to sustain the growth of the S. epidermidis strain as such. the urea gel electrophoresis (Fig. 1) . The calculated The growth assay was carried out in a total volume of 250 ml transferrin saturation values decreased and nonin microtiter wells using an initial bacterial density of about saturated iron forms reappeared in the urea gels in the 2×104/ml. Bacterial growth was monitored by measuring serum samples taken 2-3 days after the i.v. iron optical density with periodic shaking for 24 h at 37°C in a injection before the next haemodialysis session. The presence of catalytically active iron in the serum calculated for each sample by dividing the m/t lag value obtained for the serum sample by the corresponding value samples was investigated by the BDI method. ( Fig. 3A) . BDI occurred more often in patients with low serum transferrin ( Fig. 3B ). Five out of seven patients with According to our validation study, the limit of detection of the assay was 0.1 mmol/l and thus the results serum transferrin <1.8 g/l had one or more positive samples after i.v. iron-saccharate administration. On <0.1 mmol/l were regarded as negative (L. von Bonsdorff, E. Lindeberg, J. Parkkinen, unpublished the other hand, two of the five patients with serum transferrin >1.8 g/l also had BDI in the serum sample results). None of the patients were positive for BDI before i.v. iron-saccharate. The average BDI level taken 210 min after iron-saccharate. Baseline serum ferritin value before the start of i.v. iron supincreased in parallel with the average transferrin saturation level after i.v. iron-saccharate ( Table 1 ). The plementation seemed to have less influence on the appearance of BDI. Four of the six patients with serum proportion of patients having detectable BDI in serum increased correspondingly, and 210 min after i.v. iron ferritin <100 mg/l and three of the six patients with ferritin 100-400 mg/l were positive for BDI. Similarly, saccharate six of the 12 patients were positive for BDI (Fig. 2) . Seven of the patients were positive in at least there was no apparent association between transferrin saturation before i.v. iron-saccharate and the one sample after i.v. iron-saccharate. When compared appearance of BDI. Three out of six patients with initial transferrin saturation <20% and four of the six patients with initial transferrin saturation >20% had BDI in serum after iron-saccharate administration.
Bacterial growth in serum after i.v. iron-saccharate administration
The effect of the serum samples on growth of a multiple drug resistant S. epidermidis strain was studied by inoculating the serum samples with the bacteria and monitoring their growth. No growth could be detected in serum samples from healthy donors, nor in any of the patient samples taken before the i.v. iron administration ( Fig. 4) . This demonstrated the ability of serum to resist the growth of bacteria. In contrast, bacterial growth was observed in the serum of the patients, who had high transferrin saturation values after i.v. ironsaccharate ( Fig. 3C ) . Similarly to BDI, bacterial growth was most frequently observed in the serum samples taken 210 min after iron-saccharate. Bacteria grew in the serum of eight of the 12 patients at this time point. When iron-free apotransferrin was added to the serum samples, which promoted bacterial Fig. 4 . Bacterial growth curves in serum samples inoculated with growth, the ability of the serum to resist the growth S. epidermidis in vitro. The growth was measured as optical density (OD).
was restored (Fig. 4) . This confirmed that bacterial growth was critically dependent on the presence of monoferric and diferric transferrin bands increased somewhat after addition of high iron-saccharate levels non-transferrin-bound iron in the serum.
There was a good correlation (r=0.87, CI 0.79-0.92) (up to 500 mmol/l ). In the same samples, the transferrin saturation values calculated from the ferrozine method between BDI and bacterial growth index values (Fig. 3D ). There were only a few samples that pro-increased from 30 to 56%, and correlated apparently well with the urea gel results. In contrast, the iron moted slow bacterial growth without containing BDI. The lag phases before bacterial growth were clearly values obtained with the ferene-S method indicated 100% transferrin saturation already when the urea gel longer in these samples than in the samples, which were positive in the BDI assay. There was only one still revealed the presence of iron-free apotransferrin in the serum. This demonstrated that the ferene-S BDI-positive sample, which did not support bacterial growth.
method does not give accurate transferrin saturation values in the presence of iron-saccharate at concentraThe ability of bacteria to utilize iron-saccharate as an iron source was studied in vitro in normal serum tions occurring after i.v. injection.
To further study the stability of iron-saccharate in with increasing levels of added iron-saccharate. No bacterial growth was observed when iron-saccharate serum, we incubated the serum samples with added iron-saccharate up to 4 h at 37°C. After the slight was added up to 350 mmol/l calculated as iron concentration. At higher levels, slow bacterial growth was initial increase in the intensity of the monoferric or diferric transferrin bands, no further increase in transdetected but only after a prolonged lag phase. Control samples, in which transferrin had been fully saturated ferrin saturation took place on the basis of urea gel electrophoresis. Neither could catalytically active iron by adding 45 mmol/l of ferric nitrilotriacetic acid, promoted bacterial growth. The results indicated that be detected by the BDI assay in any of the samples.
These results indicated that iron-saccharate is rela-S. epidermidis cannot effectively utilize iron-saccharate directly as an iron source in serum.
tively stable in serum in vitro, and only little iron is liberated from even high concentrations of ironsaccharate during incubation in serum.
Interference of iron-saccharate with serum iron determination

Discussion
To find out whether iron-saccharate concentrations, occurring after i.v. injection, could interfere with the commonly used iron methods, we added serum sacch-In the present paper we demonstrate that an i.v. arate in vitro to normal serum up to 500 mmol/l as iron injection of 100 mg iron-saccharate resulted in full concentration. This corresponds to the highest level transferrin saturation and appearance of catalytically measured in serum by atom absorption spectrometry active iron measured as BDI in the serum of seven out 10 min after 100 mg i.v. iron-saccharate [27] . The of 12 haemodialysis patients. Transferrin saturation ferene-S method gave clearly higher results as com-and BDI reached the highest level at the end of the pared to the ferrozine method, and thus, also higher 3.5-h follow-up after i.v. iron injection. The appearance transferrin saturation values. To examine the actual of BDI was associated with loss of the ability of the transferrin saturation, the samples were studied in urea serum to resist the growth of S. epidermidis inoculated gel electrophoresis ( Fig. 5) . The intensities of the in vitro, which was restored by adding iron-free apotransferrin to the serum. This indicated that bacterial growth in the serum was dependent on non-transferrinbound iron. Sunder-Plassmann and Hö rl [15] have studied transferrin saturation in haemodialysis patients after i.v. iron-saccharate doses of 10-100 mg. They found that the i.v. administration of 100 mg iron-saccharate did not result in transferrin oversaturation if the serum transferrin concentration was >1.8 g/l. Two out of the four patients with serum transferrin <1.8 g/l had transferrin saturation values >100% during the followup time, which was 30 min after iron injection [15] . We also found more often high transferrin saturation values and BDI in patients with a low serum transferrin level. However, two of the five patients with a normal transferrin level also had fully saturated transferrin and BDI 3.5 h after i.v. iron-saccharate administra- Fig. 5 . Effect of iron-saccharate added to normal serum in vitro on tion. Other parameters like serum ferritin concentratransferrin iron forms and calculated transferrin saturation values. tion and transferrin saturation before the parenteral Transferrin iron forms were determined by urea gel electrophoresis iron injection proved to be less predictive for the similarly as in Figure 1 . Serum iron concentration used in the appearance of BDI. This suggests that it may not be calculation of transferrin saturation was determined with two different methods indicated. possible to reliably select the patients beforehand, to Catalytically active iron after i.v. iron-saccharate 1833 whom 100 mg of iron-saccharate could be adminis-in haemodialysis patients treated with i.v. iron [18, 19] , together with the pathophysiological evidence, indicate tered without the risk of transferrin oversaturation.
Banyai et al. [17] reported recently that BDI was that i.v. iron dosage regimens which may lead to transferrin oversaturation should be avoided. detectable in eight out of 10 haemodialysis patients following i.v. injection of 100 mg of iron-saccharate.
In addition to the bacterial growth promoting effect, non-transferrin-bound iron is a powerful catalyser of The time point of BDI positive samples was not reported. After lower iron-saccharate doses hydroxyl radical generation [9] and it has been associated with hepatic toxicity [11] . It remains currently (10-50 mg) BDI was detected in only two out of 15 patients. Our results confirm the finding of this earlier open whether short periods with catalytically active iron in circulation could induce cellular toxicity in report that a considerable portion of patients are positive for BDI following 100 mg i.v. iron-saccharate. haemodialysis patients.
Concerning dosage regimens of i.v. iron-saccharate It has previously been shown that serum iron assays may measure a fraction of iron present in the iron-that would not lead to oversaturation of transferrin, apparently doses lower than 100 mg with more frequent dextran complex [28] and, therefore, give false elevations in transferrin saturation after i.v. iron-dextran administration should be considered. In the assessment of dosage regimens for iron-saccharate, transferrin administration. We extended these observations to iron saccharate, which was found to interfere with the saturation should be followed at least for 3-4 h after iron injection by using a suitable method for serum ferene-S iron method and give falsely high transferrin saturation values within 30 min after i.v. injection. To iron determination, which does not measure saccharate-complexed iron. avoid the interference problem, we studied transferrin saturation by direct assessment of serum transferrin iron forms by urea gel electrophoresis. With this method we could confirm that the ferrozine serum iron References assay gave reliable transferrin saturation values even in the presence of high iron saccharate concentrations
